The medicine may be “transformational,” but doctors won’t write the script if payers don’t reimburse.
And there’s a veritable alphabet soup of players – everything from KAMs to NAMs, MSLs to MSOLs, PBMs to IDNs, and more – involved in negotiating the path to reimbursement and, ultimately, access for innovative therapies when they hit the market.
Jon Haas, Senior Director, Market Access at Syneos Health, discusses the complex process, how companies can best position their product for access and what really matters to payers in the long run.
For more on value and access in biopharma, check out:
How Competition Affects Market Access for Rare Disease Therapeutics, Part 1
How Competition Affects Market Access for Rare Disease Therapeutics, Part 2
Future-Forward Planning: What Drug and Device Manufacturers Need to Know About Preventive Drug Lists
2021 Update: Non-Personal Promotion: What Do Payers Want?
The Other Path to Access: Strategies for Direct Employer Engagement
The Syneos Health Podcast: Trade and Distribution in Pharma: It's Complicated
What to Expect on Drug Pricing in the Democratic Trifecta
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.
The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.